Immuno-Oncology Frontiers / Berlin 2017

Immuno-Oncology has established itself in recent years as one of the most exciting therapeutic areas and has experienced tremendous growth within funding and clinical trials alike. It is predicted that immunotherapies will eventually be used in as many as 60% of cases of advanced cancer.

Termin: 

20.09.2017 -  21.09.2017